MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 19; HEART-VALVE, MECHANICAL

Model Number ONXACE-19

Device Problem Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Unspecified Infection (1930); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)

Event Date 09/08/2023

Event Type  Injury  

Manufacturer Narrative

This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.

Event Description

According to the initial report the onxace-19 dehisced because of fragile pussed aortic root.Patient was transferred and thinks the patient had a homograft implanted.Per the hospital representative, "valve performed as well as it should".No additional information forthcoming.

Manufacturer Narrative

The manufacturing records for serial number (b)(6) were reviewed, and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.Document change orders (b)(4) were issued for leaflet tuning as a part of the standard manufacturing process.On 14sept2023 an artivion employee was notified on an explant of an aortic mechanical valve.This complaint is regarding onxace ¿ 19 sn (b)(6) implanted on (b)(6) 2023 in a patient of unknown age and gender.On (b)(6) 2023 onxace ¿ 19 sn (b)(6) was implanted, and we were notified via email on 14sep2023 that ¿(b)(6) let me know that the onxace-19 [valve] dehisced because of fragile pussed aortic root.Patient was transferred and thinks the patient had a homograft implanted¿.The field representative and field assurance team attempted multiple times to gather further information and the only reply was that the ¿valve performed as well as it should¿.The valve was not returned for inspection and no medical records or further details were provided.A review of the original manufacturing records shows no abnormalities.With the information provided, the source of the necrotic aortic root is unknown.However, because all on x valves undergo validated terminal sterilization prior to distribution, the valve is unlikely to be the source.With the information that the valve dehisced because of an apparent necrotic aortic root and the statement from the facility that the valve performed as well as it should, we can conclude that there was no issue with the valve, and it did not contribute to the decision to explant.There was no alleged infection, however, because all on x valves undergo validated terminal sterilization prior to distribution, the valve is unlikely to be the source of the necrotic aortic root.A product failure mode cannot be identified; thus, severity and occurrence are not evaluated.No further action is required without additional information.The root cause is unknown.With the information that the valve dehisced because of an apparent necrotic aortic root and the statement from the facility that the valve performed as well as it should, we can conclude that there was no issue with the valve, and it did not contribute to the decision to explant.There was no alleged infection, however, because all on x valves undergo validated terminal sterilization prior to distribution, the valve is unlikely to be the source of the necrotic aortic root.This event does not identify additional hazards or modify the probability and severity of existing hazards, and the ifu adequately communicates risk.This complaint was reviewed for a capa evaluation and a capa is not warranted.Field assurance will continue to monitor similar complaints to determine if additional actions are warranted; however, at this time no further actions are necessary.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.

Event Description

According to the initial report the onxace-19 dehisced because of fragile pussed aortic root.Patient was transferred and thinks the patient had a homograft implanted.Per the hospital representative, "valve performed as well as it should." no additional information forthcoming.

• Brand Name: ONX AORTIC CONFORM EXT 19
• Type of Device: HEART-VALVE, MECHANICAL
• Manufacturer (Section D): ON-X LIFE TECHNOLOGIES, INC.; 1300 e. anderson ln., bldg. b; austin TX 78752
• Manufacturer (Section G): ON-X LIFE TECHNOLOGIES, INC.; 1300 e. anderson ln., bldg. b; austin TX 78752
• Manufacturer Contact: rochelle maney ; 1655 roberts blvd. nw; kennesaw, GA 30144 ; 7704193355
• MDR Report Key: 17919571
• MDR Text Key: 325485402
• Report Number: 1649833-2023-00039
• Device Sequence Number: 1
• Product Code: LWQ
• UDI-Device Identifier: 00851788001440
• UDI-Public: 00851788001440
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P000037
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Health Professional,Company Representative
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date: 11/20/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Lay User/Patient
• Device Model Number: ONXACE-19
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: 09/14/2023
• Initial Date FDA Received: 10/12/2023
• Supplement Dates Manufacturer Received: 09/14/2023
• Supplement Dates FDA Received: 11/20/2023
• Was Device Evaluated by Manufacturer?: No
• Date Device Manufactured: 05/15/2023
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention